August 2012 
Volume 42  Number 8
Pages 13 - 13
  PDF Version Available!

To prevent thrombotic events, patients in heart failure may receive warfarin or aspirin therapy.1 To determine if warfarin therapy is superior to an aspirin regimen for patients in sinus rhythm who have a reduced left ventricular ejection fraction, researchers followed 2,305 patients for up to 6 years. The primary outcome was the time it took for a patient to experience the first event in a primary, composite end point: ischemic stroke, intracerebral hemorrhage, or death.The rates for primary outcome in the warfarin group were 7.47 events per 100 patient years and 7.93 in the aspirin group, indicating no significant difference in the treatments. The biggest distinction noted was that warfarin reduced the rate of ischemic stroke throughout the follow-up, but warfarin also increased the likelihood of a major hemorrhage. Researchers concluded that the choice between the two drugs should be determined on an individual patient basis.Source: Homma S, Thompson JL, Pullicino PM, et al. Warfarin

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events